Pharmicell (005690) — Free Cash Flow Generation Index
Pharmicell (005690) has a Free Cash Flow Generation Index of 0.93x as of September 2025. Free cash flow of ₩8.16 Billion represents 1% of operating cash flow (₩8.78 Billion). See working capital to net assets of Pharmicell to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Pharmicell Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Pharmicell across 6 annual periods. Explore debt repayment capacity of Pharmicell to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Pharmicell (2016–2024)
Year-by-year Free Cash Flow Generation Index for Pharmicell. For the full company profile including market capitalisation, see market value of Pharmicell.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.24x | ₩-839.98 Million | ₩3.50 Billion | ₩4.34 Billion | ▼ -149.0% |
| 2023 | 0.49x | ₩5.79 Billion | ₩11.81 Billion | ₩6.02 Billion | ▲ +135.1% |
| 2022 | -1.40x | ₩-11.04 Billion | ₩7.91 Billion | ₩18.96 Billion | ▼ -252.1% |
| 2020 | 0.92x | ₩8.24 Billion | ₩8.98 Billion | ₩742.73 Million | ▲ +345.5% |
| 2018 | -0.37x | ₩-1.27 Billion | ₩3.40 Billion | ₩4.68 Billion | ▼ -107.6% |
| 2016 | 4.89x | ₩4.84 Billion | ₩988.97 Million | ₩3.85 Billion | — |